2022
DOI: 10.1016/j.dyepig.2022.110765
|View full text |Cite
|
Sign up to set email alerts
|

A highly selective turn-on schiff base fluorescent sensor for diabetic biomarker beta-hydroxybutyrate (β-HB)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 25 publications
0
3
0
Order By: Relevance
“…70 An implanted fluorescent sensor has been proposed but no clinical data on this method have been reported. 71 Theoretically, a combined continuous glucose monitor (CGM) and CKM system, offering both continuous glucose and ketone data within a single system, may be feasible. 72 Another method under development would be with a microneedle sampling method with a sensor array, which could measure interstitial fluid ketone levels and potentially also measure other analytes, such as glucose and lactate.…”
Section: The Principle Of Continuous Ketone Monitoringmentioning
confidence: 99%
“…70 An implanted fluorescent sensor has been proposed but no clinical data on this method have been reported. 71 Theoretically, a combined continuous glucose monitor (CGM) and CKM system, offering both continuous glucose and ketone data within a single system, may be feasible. 72 Another method under development would be with a microneedle sampling method with a sensor array, which could measure interstitial fluid ketone levels and potentially also measure other analytes, such as glucose and lactate.…”
Section: The Principle Of Continuous Ketone Monitoringmentioning
confidence: 99%
“…[1][2][3] It is reported that almost 500 million people are suffering from diabetes or prediabetes, and the influenced population is constantly expanding. 4 Significantly, due to the disturbance of the metabolism triggered by diabetes, diabetic patients are always tortured by many complications including kidney diseases, coronary heart disease, cerebrovascular disease, etc. 5 Lately, a-glucosidase (a-Glu) has been considered as one of the most crucial therapeutic targets of diabetes.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, several studies on SBs-metal complexes showed their use as anti-Alzheimer agents [ 15 , 16 , 17 ], and their potential in the management of diabetes mellitus [ 18 ]. Some SBs derivatives have demonstrated α-glucosidase inhibition and antiglycation activity [ 19 , 20 ], whereas other derivatives were synthesized and used as fluorescent sensors for the diabetic biomarker beta-hydroxybutyrate (β-HB) [ 21 ]. Metal complexes of different metals with SBs have demonstrated a myriad of activities [ 22 , 23 ], and catalytic applications [ 24 ] in which metals are represented by Mo [ 25 ], Cu [ 26 , 27 , 28 ], Zr [ 29 , 30 , 31 ], Pd [ 32 ], Cu [ 33 ], Ni [ 34 ], Ru [ 35 ], Mn [ 36 ], Zn [ 37 , 38 ] and W [ 39 ].…”
Section: Introductionmentioning
confidence: 99%